Altered lymphocyte responses and cytokine production in mice deficient in the X-linked lymphoproliferative disease gene SH2D1A/DSHP/SAP

被引:219
作者
Czar, MJ
Kersh, EN
Mijares, LA
Lanier, G
Lewis, J
Yap, G
Chen, A
Sher, A
Duckett, CS
Ahmed, R
Schwartzberg, PL
机构
[1] NHGRI, NIH, Bethesda, MD 20892 USA
[2] NCI, NIH, Bethesda, MD 20892 USA
[3] NIAID, NIH, Bethesda, MD 20892 USA
[4] Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA
[5] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA
关键词
D O I
10.1073/pnas.131193098
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
We have introduced a targeted mutation in SH2D1A/DSHP/SAP, the gene responsible for the human genetic disorder X-linked lymphoproliferative disease (XLP). SLAM-associated protein (SAP)-deficient mice had normal lymphocyte development, but on challenge with infectious agents, recapitulated features of XLP. Infection of SAP(-) mice with lymphocyte choriomeningitis virus (LCMV) or Toxoplasma gondii was associated with increased T cell activation and IFN-gamma production, as well as a reduction of Ig-secreting cells. Anti-CD3-stimulated splenocytes from uninfected SAP(-) mice produced increased IFN-gamma and decreased IL-4, findings supported by decreased serum IgE levels in vivo. The Th1 skewing of these animals suggests that cytokine misregulation may contribute to phenotypes associated with mutation of SH2D1A/SAP.
引用
收藏
页码:7449 / 7454
页数:6
相关论文
共 35 条
[1]   SELECTION OF GENETIC-VARIANTS OF LYMPHOCYTIC CHORIOMENINGITIS VIRUS IN SPLEENS OF PERSISTENTLY INFECTED MICE - ROLE IN SUPPRESSION OF CYTO-TOXIC LYMPHOCYTE-T RESPONSE AND VIRAL PERSISTENCE [J].
AHMED, R ;
SALMI, A ;
BUTLER, LD ;
CHILLER, JM ;
OLDSTONE, MBA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 160 (02) :521-540
[2]   SLAM and its role in T cell activation and Th cell responses [J].
Aversa, G ;
Carballido, J ;
Punnonen, J ;
Chang, CCJ ;
Hauser, T ;
Cocks, BG ;
DeVries, JE .
IMMUNOLOGY AND CELL BIOLOGY, 1997, 75 (02) :202-205
[3]  
Aversa G, 1997, J IMMUNOL, V158, P4036
[4]   Cutting edge: Defective NK cell activation in X-linked lymphoproliferative disease [J].
Benoit, L ;
Wang, XX ;
Pabst, HF ;
Dutz, J ;
Tan, R .
JOURNAL OF IMMUNOLOGY, 2000, 165 (07) :3549-3553
[5]   Epstein-Barr virus-negative boys with non-Hodgkin lymphoma are mutated in the SH2D1A gene, as are patients with X-linked lymphoproliferative disease (XLP) [J].
Brandau, O ;
Schuster, V ;
Weiss, M ;
Hellebrand, H ;
Fink, FM ;
Kreczy, A ;
Friedrich, W ;
Strahm, B ;
Niemeyer, C ;
Belohradsky, BH ;
Meindl, A .
HUMAN MOLECULAR GENETICS, 1999, 8 (13) :2407-2413
[6]  
Castro AG, 1999, J IMMUNOL, V163, P5860
[7]   A NOVEL RECEPTOR INVOLVED IN T-CELL ACTIVATION [J].
COCKS, BG ;
CHANG, CCJ ;
CARBALLIDO, JM ;
YSSEL, H ;
DEVRIES, JE ;
AVERSA, G .
NATURE, 1995, 376 (6537) :260-263
[8]   Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene [J].
Coffey, AJ ;
Brooksbank, RA ;
Brandau, O ;
Oohashi, T ;
Howell, GR ;
Bye, JM ;
Cahn, AP ;
Durham, J ;
Heath, P ;
Wray, P ;
Pavitt, R ;
Wilkinson, J ;
Leversha, M ;
Huckle, E ;
Shaw-Smith, CJ ;
Dunham, A ;
Rhodes, S ;
Schuster, V ;
Porta, G ;
Yin, L ;
Serafini, P ;
Sylla, B ;
Zollo, M ;
Franco, B ;
Bolino, A ;
Seri, M ;
Lanyi, A ;
Davis, JR ;
Webster, D ;
Harris, A ;
Lenoir, G ;
St Basile, GD ;
Jones, A ;
Behloradsky, BH ;
Achatz, H ;
Murken, J ;
Fassler, R ;
Sumegi, J ;
Romeo, G ;
Vaudin, M ;
Ross, MT ;
Meindl, A ;
Bentley, DR .
NATURE GENETICS, 1998, 20 (02) :129-135
[9]   X-CHROMOSOME INACTIVATION PATTERNS IN OBLIGATE CARRIERS OF X-LINKED LYMPHOPROLIFERATIVE SYNDROME [J].
CONLEY, ME ;
SULLIVAN, JL ;
NEIDICH, JA ;
PUCK, JM .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1990, 55 (03) :486-491
[10]   IMMUNOGLOBULIN CLASS AND SUBCLASS DEFICIENCIES PRIOR TO EPSTEIN-BARR-VIRUS INFECTION IN MALES WITH X-LINKED LYMPHOPROLIFERATIVE DISEASE [J].
GRIERSON, HL ;
SKARE, J ;
HAWK, J ;
PAUZA, M ;
PURTILO, DT .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1991, 40 (03) :294-297